ASX listed biotech, PharmAust, has put a call out for canine volunteers to join its anti-cancer drug treatment trials in partnership with veterinary practices across Australia. The trials will study the effectiveness of Pharmaust’s anti-cancer drug in dogs suffering from B cell lymphoma – the most common canine cancer. Preliminary findings from phase I trials were very positive, with a notable reduction in tumours and prolonged lifespan.
04/11/2019 - 08:38
Pharmaust calls for K9 volunteers for cancer drug trials
By Matt Birney
04/11/2019 - 08:38
Related Data & Insights
-
-
Rank Company Revenue 128th PharmAust $3.8m 137th Adisyn $2.9m 138th rent.com.au $2.8m 141st Douugh $2.5m 142nd Hazer Group $2.4m 201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Related Articles
05 Feb 2024
Board Moves February 5, 2024
28 Aug 2023
Board Moves August 28, 2023
23 Jul 2021
PharmAust looks to patent anti-cancer drug
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX